Learning Objectives
Upon completion of this activity, participants should be better able to:
- Review the latest evidence regarding the use of neoadjuvant treatment for patients with melanoma and the implications for clinical decision-making.
- Evaluate patient and tumor characteristics that may help identify patients who may benefit from CPI-based adjuvant therapy based on the latest clinical evidence.
- Examine the patient, tumor, and/or treatment characteristics that may help guide clinical decision-making for patients with recurrent melanoma.